Is a complete CLRB research report available?

No complete published report is available for Cellectar Biosciences, Inc. (CLRB) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Cellectar Biosciences, Inc. (CLRB)

NASDAQ: CLRB · USD

$1.25

+0.04 (+3.3%)· Recorded snapshot

Market cap	11.8M
Net income (ttm)	-22.3M
EPS (ttm)	-$3.75
Shares out	9.5M
Volume	56,484
Beta	0.58

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -22.3M
EPS (ttm): -$3.75
Market cap: 11.8M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Halten

Metric	Value
Amount currency	USD
CIK code	0001279704
Company name	Cellectar Biosciences, Inc.
Country	United States
Country code	US
CUSIP number	15117F880
Earnings date	2026-11-12
Earnings time	bmo
Employees	11
Employees change	-9
Employees growth	-45%
Enterprise value	$-20.6M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2002
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	US15117F8804
Last 10-K release date	2026-03-04
Last earnings date	2026-08-13
Last refreshed	2026-10-28
Last stock split date	2025-06-24
Last stock split type	Reverse
Market cap	$11.8M
Market cap category	Nano-Cap
Next earnings date	2026-11-12
Options	No
Price	$1.25
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	CLRB
U.S. state	New Jersey
Website	https://www.cellectar.com

Metric

Value

Amount currency

USD

CIK code

0001279704

Company name

Cellectar Biosciences, Inc.

Country

United States

Country code

CUSIP number

15117F880

Earnings date

2026-11-12

Earnings time

bmo

Employees

Employees change

-9

Employees growth

-45%

Enterprise value

$-20.6M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2002

Industry

Biotechnology

Is primary listing

Yes

Is SPAC

ISIN number

US15117F8804

Last 10-K release date

2026-03-04

Last earnings date

2026-08-13

Last refreshed

2026-10-28

Last stock split date

2025-06-24

Last stock split type

Reverse

Market cap

$11.8M

Market cap category

Nano-Cap

Next earnings date

2026-11-12

Options

Price

$1.25

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

CLRB

U.S. state

New Jersey

Website

https://www.cellectar.com

Metric	Value
Earnings yield	-300.1%
FCF / EV yield	93.71%
FCF yield	-166.95%
P/B ratio	0.33x
Price / tangible book value	0.39x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Earnings yield

-300.1%

FCF / EV yield

93.71%

FCF yield

-166.95%

P/B ratio

0.33x

Price / tangible book value

0.39x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
Profit per employee	$-2M
ROA	-58.44%
ROA (5Y)	-96.15%
ROCE	-74.94%
ROE	-119.57%
ROIC	-74.8%

Metric

Value

Profit per employee

$-2M

ROA

-58.44%

ROA (5Y)

-96.15%

ROCE

-74.94%

ROE

-119.57%

ROIC

-74.8%

Metric	Value
EPS growth quarters	2
EPS growth years	3
Net income growth years	1
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Net income growth years

Revenue growth years

Metric	Value
Capital expenditures	$-9,258
Depreciation and amortization	$172,786
EBIT	$-23.5M
EBITDA	$-23.4M
EPS	$-3.75
FCF per share	$-2.06
Financing cash flow	$42.4M
Free cash flow	$-19.5M
Free cash flow minus SBC	$-21.5M
Investing cash flow	$-9,258
Net cash flow	$23M
Net income	$-22.3M
Operating cash flow minus SBC	$-21.5M
Operating income	$-23.5M
Stock-based compensation	$2M

Metric

Value

Capital expenditures

$-9,258

Depreciation and amortization

$172,786

EBIT

$-23.5M

EBITDA

$-23.4M

EPS

$-3.75

FCF per share

$-2.06

Financing cash flow

$42.4M

Free cash flow

$-19.5M

Free cash flow minus SBC

$-21.5M

Investing cash flow

$-9,258

Net cash flow

$23M

Net income

$-22.3M

Operating cash flow minus SBC

$-21.5M

Operating income

$-23.5M

Stock-based compensation

$2M

Metric	Value
Book value per share	$3.62
Debt / equity	0.05
Long-term assets	$1.8M
Long-term liabilities	$1.5M
Net cash (debt)	$32.5M
Net cash / market cap	278.16%
Net cash growth	206.61%
Net debt / equity	-1.09
Piotroski F-Score	2
Property, plant and equipment	$1.7M
Shareholders' equity	$29.9M
Tangible book value	$29.9M
Tangible book value per share	$3.62
Total assets	$36.6M
Total cash	$34M
Total debt	$1.5M
Total liabilities	$6.8M
WACC	6.56%

Metric

Value

Book value per share

$3.62

Debt / equity

0.05

Long-term assets

$1.8M

Long-term liabilities

$1.5M

Net cash (debt)

$32.5M

Net cash / market cap

278.16%

Net cash growth

206.61%

Net debt / equity

-1.09

Piotroski F-Score

Property, plant and equipment

$1.7M

Shareholders' equity

$29.9M

Tangible book value

$29.9M

Tangible book value per share

$3.62

Total assets

$36.6M

Total cash

$34M

Total debt

$1.5M

Total liabilities

$6.8M

WACC

6.56%

Metric	Value
Current assets	$34.9M
Current liabilities	$5.2M
Current ratio	6.66
Net working capital	$-4.4M
Quick ratio	6.49
Working capital	$29.6M

Metric

Value

Current assets

$34.9M

Current liabilities

$5.2M

Current ratio

6.66

Net working capital

$-4.4M

Quick ratio

6.49

Working capital

$29.6M

Metric	Value
Buyback yield / dilution	-306.49%
Dividend yield	0%
Shareholder yield	-306.49%

Metric

Value

Buyback yield / dilution

-306.49%

Dividend yield

Shareholder yield

-306.49%

Metric	Value
10Y price change	-99.98%
10Y return CAGR	-56.85%
10Y total return	-99.98%
150-day SMA	$2.46
15Y price change	-100%
15Y return CAGR	-57.78%
15Y total return	-100%
1D price change	3.31%
1M price change	-31.67%
1M total return	-31.67%
1Y price change	-65.74%
1Y return CAGR	-65.76%
1Y total return	-65.74%
20-day SMA	$1.36
200-day SMA	$2.66
3M price change	-49.17%
3M total return	-49.17%
3Y price change	-98.26%
3Y return CAGR	-74.06%
3Y total return	-98.26%
50-day SMA	$1.94
50-day SMA vs 200-day SMA	50under200
52-week high	$4.70
52-week high date	2026-05-05
52-week low	$1.12
52-week low date	2026-10-20
5Y price change	-99.52%
5Y return CAGR	-65.62%
5Y total return	-99.52%
6M price change	-52.87%
6M total return	-52.87%
All-time high	$1,799,964.00
All-time high date	2011-04-11
All-time low	$1.12
All-time low date	2026-10-16
Average true range (ATR)	$0.13
Average volume	170.6K
Beta (1Y)	1.76
Beta (2Y)	1.28
Beta (5Y)	0.58
Change from 52-week high	-73.4%
Change from 52-week low	11.61%
Change from all-time high	-100%
Change from all-time low	9.82%
Change from open	3.73%
Day's gap	-0.41%
Dollar volume	$70,605
High price	$1.26
Low price	$1.20
Monthly RSI	26.35
Open price	$1.21
Position in 52-week range	83.33%
Premarket change	2.48%
Premarket close	$1.21
Premarket price	$1.24
Previous close	$1.21
Price vs 150-day SMA	-50.06%
Price vs 20-day SMA	-9.56%
Price vs 200-day SMA	-53.76%
Price vs 50-day SMA	-36.63%
Relative volume	0.33
RSI	30.51
Sharpe ratio	-1.03
Sharpe ratio (3Y)	-0.8
Sharpe ratio (5Y)	-0.66
Sortino ratio	-1.37
Sortino ratio (3Y)	-1.02
Sortino ratio (5Y)	-0.87
Volume	56.5K
Weekly RSI	28.43
YTD price change	-58.31%
YTD total return	-58.31%

Metric

Value

10Y price change

-99.98%

10Y return CAGR

-56.85%

10Y total return

-99.98%

150-day SMA

$2.46

15Y price change

-100%

15Y return CAGR

-57.78%

15Y total return

-100%

1D price change

3.31%

1M price change

-31.67%

1M total return

-31.67%

1Y price change

-65.74%

1Y return CAGR

-65.76%

1Y total return

-65.74%

20-day SMA

$1.36

200-day SMA

$2.66

3M price change

-49.17%

3M total return

-49.17%

3Y price change

-98.26%

3Y return CAGR

-74.06%

3Y total return

-98.26%

50-day SMA

$1.94

50-day SMA vs 200-day SMA

50under200

52-week high

$4.70

52-week high date

2026-05-05

52-week low

$1.12

52-week low date

2026-10-20

5Y price change

-99.52%

5Y return CAGR

-65.62%

5Y total return

-99.52%

6M price change

-52.87%

6M total return

-52.87%

All-time high

$1,799,964.00

All-time high date

2011-04-11

All-time low

$1.12

All-time low date

2026-10-16

Average true range (ATR)

$0.13

Average volume

170.6K

Beta (1Y)

1.76

Beta (2Y)

1.28

Beta (5Y)

0.58

Change from 52-week high

-73.4%

Change from 52-week low

11.61%

Change from all-time high

-100%

Change from all-time low

9.82%

Change from open

3.73%

Day's gap

-0.41%

Dollar volume

$70,605

High price

$1.26

Low price

$1.20

Monthly RSI

26.35

Open price

$1.21

Position in 52-week range

83.33%

Premarket change

2.48%

Premarket close

$1.21

Premarket price

$1.24

Previous close

$1.21

Price vs 150-day SMA

-50.06%

Price vs 20-day SMA

-9.56%

Price vs 200-day SMA

-53.76%

Price vs 50-day SMA

-36.63%

Relative volume

0.33

RSI

30.51

Sharpe ratio

-1.03

Sharpe ratio (3Y)

-0.8

Sharpe ratio (5Y)

-0.66

Sortino ratio

-1.37

Sortino ratio (3Y)

-1.02

Sortino ratio (5Y)

-0.87

Volume

56.5K

Weekly RSI

28.43

YTD price change

-58.31%

YTD total return

-58.31%

Metric	Value
Float	9.3M
Float percentage	98.17%
Shares change (QoQ)	188.48%
Shares change (YoY)	306.49%
Shares held by insiders	1.83%
Shares held by institutions	40.88%
Shares outstanding	9.5M
Short % of float	2.84%
Short % of shares	2.79%
Short ratio	2.7 days

Metric

Value

Float

9.3M

Float percentage

98.17%

Shares change (QoQ)

188.48%

Shares change (YoY)

306.49%

Shares held by insiders

1.83%

Shares held by institutions

40.88%

Shares outstanding

9.5M

Short % of float

2.84%

Short % of shares

2.79%

Short ratio

2.7 days

Cellectar Biosciences, Inc. (CLRB)

Price

Financial snapshot

Fair-value bridge

Latest news · CLRB

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CLRB indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CLRB

Frequently asked questions